Mankind Pharma Limited (NSE:MANKIND)

Mankind Pharma Statistics

Total Valuation

Mankind Pharma has a market cap or net worth of INR 926.95 billion. The enterprise value is 978.08 billion.

Market Cap	926.95B
Enterprise Value	978.08B

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	n/a

Share Statistics

Mankind Pharma has 412.81 million shares outstanding. The number of shares has increased by 2.76% in one year.

Current Share Class	412.81M
Shares Outstanding	412.81M
Shares Change (YoY)	+2.76%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	57.71%
Owned by Institutions (%)	20.71%
Float	106.31M

Valuation Ratios

The trailing PE ratio is 51.97 and the forward PE ratio is 39.78. Mankind Pharma's PEG ratio is 2.40.

PE Ratio	51.97
Forward PE	39.78
PS Ratio	6.66
PB Ratio	5.97
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	2.40

Enterprise Valuation

EV / Earnings	54.97
EV / Sales	7.03
EV / EBITDA	30.04
EV / EBIT	39.15
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.54
Debt / EBITDA	2.58
Debt / FCF	n/a
Interest Coverage	3.66

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	10.07%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	5.22%
Revenue Per Employee	7.09M
Profits Per Employee	906,906
Employee Count	19,620
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Mankind Pharma has paid 3.81 billion in taxes.

Income Tax	3.81B
Effective Tax Rate	17.42%

Stock Price Statistics

The stock price has decreased by -2.96% in the last 52 weeks. The beta is 0.15, so Mankind Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.15
52-Week Price Change	-2.96%
50-Day Moving Average	2,143.91
200-Day Moving Average	2,356.98
Relative Strength Index (RSI)	60.36
Average Volume (20 Days)	507,157

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mankind Pharma had revenue of INR 139.14 billion and earned 17.79 billion in profits. Earnings per share was 43.10.

Revenue	139.14B
Gross Profit	97.74B
Operating Income	24.87B
Pretax Income	21.89B
Net Income	17.79B
EBITDA	32.33B
EBIT	24.87B
Earnings Per Share (EPS)	43.10

Balance Sheet

The company has 34.99 billion in cash and 83.69 billion in debt, with a net cash position of -48.70 billion or -117.97 per share.

Cash & Cash Equivalents	34.99B
Total Debt	83.69B
Net Cash	-48.70B
Net Cash Per Share	-117.97
Equity (Book Value)	155.29B
Book Value Per Share	370.26
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 70.25%, with operating and profit margins of 17.87% and 12.79%.

Gross Margin	70.25%
Operating Margin	17.87%
Pretax Margin	15.73%
Profit Margin	12.79%
EBITDA Margin	23.24%
EBIT Margin	17.87%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.09%.

Dividend Per Share	2.00
Dividend Yield	0.09%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-2.76%
Shareholder Yield	-2.67%
Earnings Yield	1.92%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2